Login / Signup

Outcome of chemotherapy with or without targeted agents in metastatic colorectal cancer patients with deficient DNA mismatch repair: A single center, cohort study.

Yue YuJianming YingWen ZhangWeihua LiYongkun SunLin YangChengxu CuiYixin ZengAiping Zhou
Published in: Asia-Pacific journal of clinical oncology (2019)
dMMR mCRC seems resistant to chemotherapy and cetuximab. Bevacizumab combined therapy shows a sign of potentially favorable outcome in this subtype.
Keyphrases
  • metastatic colorectal cancer
  • locally advanced
  • circulating tumor
  • cell free
  • cancer therapy
  • squamous cell carcinoma
  • rectal cancer
  • drug delivery
  • wild type